samedan logo
 
 
 
spacer
home > ebr > spring 2008 > modular solutions for low resolution
PUBLICATIONS
European Biopharmaceutical Review

Modular Solutions for Low Resolution

Nick Barnett of Ocean Optics discusses how modular Raman spectroscopy can be used in the measurement of pharmaceutical active ingredients and excipients

Raman spectroscopy is an extremely useful technique for chemical analysis. Raman measurements are non-destructive, require very limited sample preparation and allow for sample volumes in the microlitre range. Raman techniques can even be used to acquire data through vial walls, pill pack windows and bags packaging forms that are frequently used in the biomedical and pharmaceutical industries.

In recent years, low resolution Raman spectroscopy (LRRS) has gained increased attention and acceptance in the analytical laboratory as an affordable, robust and convenient alternative to cumbersome wet chemical analysis or expensive FT-Raman and FT-IR spectrometers. Unlike high-resolution Raman spectrometers that are often capable of resolving peaks of less than three or four wave numbers apart, the new miniaturised systems relinquish resolution in favour of emphasising basic identifying spectral features, or fingerprints, that are often distinct and clearly separated. Recent advances allow some of the high-end LRRS systems to compete around the four cm-1 resolution.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Nick Barnett is the Country Manager for the UK and Ireland at Ocean Optics. He has an MSc in Optoelectronics and Laser Devices and a PhD in Biomedical Optics. Nick has previously worked in various R&D roles working on optical sensors, laser Doppler and NIR spectroscopy. He has been working for Ocean Optics for five years where his responsibilities include full business development, sales and technical support.
spacer
Nick Barnett
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sphere Fluidics closes a $40 million funding round led by Sofinnova Partners and Redmile Group

Cambridge, UK, 28 October 2021: Sphere Fluidics, a company that has developed and is commercialising single cell analysis systems underpinned by its proprietary picodroplet technology, announced today that it has closed a $40 million (circa 30 million) investment round. The round was led by Sofinnova Partners (Paris, France) and Redmile Group (San Francisco, USA) co-investing on equal terms.
More info >>

White Papers

Running Smarter Trials With Data-Driven Monitoring

PAREXEL

Clinical monitoring remains one of the most important and most costly activities in the clinical research paradigm.  Monitoring provides the operational transparency required by investigators, sponsors, and regulators to make informed decisions about site performance, patient safety, and overall study progress. Yet unlike many clinical trial activities, which have been steadily transformed by technology, the monitoring function itself has changed little.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement